By cyoder

An Indianapolis medical-software firm is expanding its reach into the fast-growing areas of opioid prescription management and precision medicine, in which treatment is determined in part by genetic testing.

bostic-brad-mug-tech-executive.jpg Bostic
Hc1.com recently raised $10 million in venture funding and is launching two cloud-based products this month that will “transform and personalize the way health care is delivered,” said Brad Bostic, who founded the firm in 2011 and is chairman and CEO.

Subscribe to the blog
Previous Post hc1 Expands Focus on Precision Health Solution, Completes Series B Round
Next Post hc1.com® Breakthrough Precision Health Offering Optimizes Prescribing